FAM168A Activators
FAM168A is a gene that has been the subject of interest within the field of molecular genetics for its role in cellular processes. Research suggests that FAM168A is involved in the nervous system's development and function, although the precise mechanisms by which it operates are not wholly understood. The gene's expression levels can be critical for the proper functioning of various molecular pathways. Regulation of gene expression is a complex interplay of factors that include the surrounding chemical environment of the cell. Various chemicals have been identified that can potentially induce the expression of genes like FAM168A, and these chemicals often function by interacting with cellular machinery that controls gene transcription.
For instance, compounds like 5-Azacytidine and Valproic Acid are known to affect chromatin structure and modify DNA and histones, respectively. These changes can lead to an upsurge in the expression of several genes, potentially including FAM168A. 5-Azacytidine can cause demethylation of DNA, which might remove silencing marks from the FAM168A gene, thereby upregulating its expression. On the other hand, Valproic Acid, by inhibiting histone deacetylase, can result in a more open chromatin state around the FAM168A locus, facilitating transcriptional activation. Other chemicals, such as Forskolin, Retinoic Acid, and Beta-Estradiol, exert their effects through different pathways. Forskolin increases intracellular cAMP, which can lead to the activation of transcription factors that target the FAM168A gene. Retinoic Acid and Beta-Estradiol, through their respective receptor-mediated signaling pathways, can bind to specific response elements on DNA and initiate transcription. Such detailed understanding of gene regulation is essential for a comprehensive grasp of cellular function and the potential modulation of gene expression by endogenous and exogenous compounds.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may directly upregulate FAM168A by causing the hypomethylation of its gene promoter region, thereby enhancing transcriptional activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid could upregulate FAM168A expression by inhibiting histone deacetylase, leading to hyperacetylation of histones near the FAM168A locus and subsequent transcriptional activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could directly increase FAM168A expression by binding to retinoic acid receptors, which may interact with retinoic acid response elements in the gene's promoter. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol may upregulate FAM168A by engaging estrogen receptors, which could bind to estrogen response elements on the FAM168A gene and promote transcriptional activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride may induce FAM168A by inhibiting GSK-3β, potentially leading to activation of transcription factors in the Wnt signaling pathway that increase transcription of Wnt target genes, including possibly FAM168A. | ||||||
(±)-Methyl Jasmonate | 39924-52-2 | sc-205386 sc-205386A sc-205386B sc-205386C sc-205386D sc-205386E sc-205386F | 1 g 5 g 10 g 50 g 100 g 500 g 1 kg | $36.00 $105.00 $204.00 $890.00 $1671.00 $7081.00 $12491.00 | ||
Methyl Jasmonate could upregulate FAM168A expression through a stress response mechanism that alters gene expression patterns, leading to a compensatory increase in neural protective or developmental genes like FAM168A. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate might increase the expression of FAM168A by inhibiting histone deacetylation, thus allowing a more relaxed chromatin state and greater accessibility of transcriptional machinery to the FAM168A gene. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein has the potential to upregulate FAM168A by inhibiting tyrosine kinases, which may alter cellular signaling cascades and result in increased transcription of genes involved in cell survival and neuroprotection. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could induce FAM168A expression by engaging glucocorticoid receptors that may bind to glucocorticoid response elements in the promoter of FAM168A, leading to enhanced gene transcription. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin may lead to an upregulation of FAM168A through the induction of the unfolded protein response, as a cellular reaction to the stress caused by inhibited glycosylation. | ||||||